Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel

Dual oral antiplatelet therapy, aspirin plus thienopyridine, has permitted a rapid increase in the use of coronary intervention procedures. Clopidogrel is the thienopyridine of choice for dual antiplatelet therapy in patients treated with percutaneous coronary intervention. However, there are two is...

Descripción completa

Detalles Bibliográficos
Autores principales: Motovska, Zuzana, Widimsky, Petr
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686264/
https://www.ncbi.nlm.nih.gov/pubmed/19475783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686264/
https://www.ncbi.nlm.nih.gov/pubmed/19475783

Ejemplares similares